HOME >> MEDICINE >> NEWS
Media availability

Meet leaders in cancer research, ask questions and discuss innovative science with the experts.

WHAT: Members of the press are cordially invited to meet with the speakers from AACR's Annual Meeting opening plenary session, taking place 8 a.m. PDT, Sunday, April 17, 2005 at the Anaheim Convention Center, Anaheim, Calif.

WHEN: This media availability will follow the plenary session, which ends at 11:30 a.m. PDT

WHERE: AACR Press Briefing Room, second floor, Anaheim Convention Center, Room 211-A

WHO: Participants in the session include:

Michael B. Kastan, M.D., Ph.D., Cancer Center Director and Chairman, Department of Hematology/Oncology, St. Jude Children's Research Hospital, Memphis, Tenn. Dr. Kastan is a practicing oncologist whose laboratory research focuses on radiation biology, DNA damage and repair, tumor suppressor genes, determinants of chemosensitivity and radiosensitivity, and causes of cancer. Dr. Kastan made the seminal discovery that the p53 tumor suppressor protein participates in cellular responses to DNA damage. More recently, his lab demonstrated how the ATM protein is activated by DNA damage. Dr. Kastan is the 2005 AACR Annual Meeting Chairperson and, as such, he is chairing the opening plenary session, entitled "The Impact of Scientific Discovery on Cancer Diagnosis and Treatment."

Clifton Leaf, executive editor, Fortune Magazine. Mr. Leaf helps oversee the magazine's editorial coverage and staff, and directs Fortune's Wall Street and investing coverage. His March 22, 2004 cover story, "Why We're Losing the War on Cancer (and How to Win It)," generated much discussion in the cancer research community.

Tyler E. Jacks, Ph.D., the David H. Koch Professor of Biology, the Director of the Center for Cancer Research at MIT, and investigator with the Howard Hughes Medical Institute. Dr. Jack's laboratory has pioneered and constructed a series o
'"/>

Contact: Yarissa Ortiz
ortiz@aacr.org
215-440-9300
American Association for Cancer Research
8-Apr-2005


Page: 1 2 3

Related medicine news :

1. Media coverage of autism differs dramatically
2. Media availability: New results show some severe emphysema patients continue to benefit from surgery
3. Media availability: Drug found to help scleroderma patients
4. Media alert: Register now for the largest obesity conference in North America
5. Media availability: Long-term survival of heart attack patients with shock
6. The IOF World Congress on Osteoporosis (IOF WCO) Opening Media Briefing June 2
7. Webcast: Media coverage of health
8. Media alert: Hazeldens chief medical director available to comment on drug treatment for alcoholics
9. Media telebriefing on new census, NIH status report citing dramatic shifts in US aging
10. Media invitation: 4th International Conference on Teenage and Young Adult Cancer Medicine
11. Media violence linked to concentration, self-control

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Media availability

(Date:8/1/2014)... Market Publishers Ltd announces that ... added to its catalogue. , Pharmaceutical ... Contract Research and Manufacturing Services (CRAMS), Biosimilars, Generics ... include, among others, increasing ageing population, rising incomes ... the pharma market in India is anticipated to ...
(Date:8/1/2014)... Patients with the progressive, deadly respiratory ailment known as ... to battle the disease, the U.S. Food and Drug ... new treatment, an inhaled spray called Striverdi Respimat (olodaterol) ... which is often linked to smoking, involves multiple lung ... Patients with COPD may experience a number of symptoms, ...
(Date:8/1/2014)... North America Endpoint Security Market report defines and segments ... analysis and forecast of revenue. This market is estimated ... $4.77 billion by 2019, at a CAGR of 6.2% ... of the North America Endpoint Security Market report to ... also provides a glimpse of the segmentation in market, ...
(Date:8/1/2014)... Scientists at Albert Einstein College of Medicine ... in digestion help keep the intestinal lining intact. The ... could yield new therapies for inflammatory bowel disease (IBD) ... research involved the intestinal microbiome, which contains some 100 ... or preventing disease is a major emerging field of ...
(Date:8/1/2014)... By Kathleen Doheny ... (HealthDay News) -- Birth control pills containing high doses ... the risk of breast cancer in women under 50, ... oral contraceptive formulations," explained lead researcher Elisabeth Beaber, a ... in Seattle. "Some of these formulations increase breast cancer ...
Breaking Medicine News(10 mins):Health News:In-demand Markets Research Reports by Kelly Scientific Publications Now Available at MarketPublishers.com 2Health News:In-demand Markets Research Reports by Kelly Scientific Publications Now Available at MarketPublishers.com 3Health News:FDA Approves New Treatment for People With COPD 2Health News:North America End-Point Security Market is Expected to Reach $4 billion in 2019 - New Report by MicroMarket Monitor 2Health News:North America End-Point Security Market is Expected to Reach $4 billion in 2019 - New Report by MicroMarket Monitor 3Health News:North America End-Point Security Market is Expected to Reach $4 billion in 2019 - New Report by MicroMarket Monitor 4Health News:'Normal' bacteria vital for keeping intestinal lining intact 2Health News:Some Birth Control Pills May Up Breast Cancer Risk 2Health News:Some Birth Control Pills May Up Breast Cancer Risk 3
(Date:7/31/2014)... 31, 2014 Pharmacyclics, Inc. (the "Company") (Nasdaq: ... for the quarter ended June 30, 2014. Financial ... 2014 Revenue Total revenue for the quarter ended June ... the quarter ended June 30, 2013 primarily due to IMBRUVICA ... Total revenue for the six months ended June ...
(Date:7/31/2014)... Therapeutics (Nasdaq: NKTR ) today reported its financial ... Cash and investments in marketable securities at June ... at March 31, 2014."The second half of 2014 will be ... significant milestones for a number of our late-stage clinical programs," ... Nektar. "The first of these is the potential US and ...
(Date:7/31/2014)... , July 31, 2014   Auxilium Pharmaceuticals , ... specialty biopharmaceutical company, today announced that the Company will ... Thursday, August 7, 2014 before the opening of the ... conference call that day at 8:30 a.m. ET to ... 2014. The presentation slides to be used during the ...
Breaking Medicine Technology:Pharmacyclics Reports Second Quarter 2014 Results 2Pharmacyclics Reports Second Quarter 2014 Results 3Pharmacyclics Reports Second Quarter 2014 Results 4Pharmacyclics Reports Second Quarter 2014 Results 5Pharmacyclics Reports Second Quarter 2014 Results 6Pharmacyclics Reports Second Quarter 2014 Results 7Pharmacyclics Reports Second Quarter 2014 Results 8Pharmacyclics Reports Second Quarter 2014 Results 9Pharmacyclics Reports Second Quarter 2014 Results 10Pharmacyclics Reports Second Quarter 2014 Results 11Pharmacyclics Reports Second Quarter 2014 Results 12Pharmacyclics Reports Second Quarter 2014 Results 13Pharmacyclics Reports Second Quarter 2014 Results 14Pharmacyclics Reports Second Quarter 2014 Results 15Pharmacyclics Reports Second Quarter 2014 Results 16Pharmacyclics Reports Second Quarter 2014 Results 17Pharmacyclics Reports Second Quarter 2014 Results 18Pharmacyclics Reports Second Quarter 2014 Results 19Pharmacyclics Reports Second Quarter 2014 Results 20Pharmacyclics Reports Second Quarter 2014 Results 21Pharmacyclics Reports Second Quarter 2014 Results 22Pharmacyclics Reports Second Quarter 2014 Results 23Pharmacyclics Reports Second Quarter 2014 Results 24Pharmacyclics Reports Second Quarter 2014 Results 25Pharmacyclics Reports Second Quarter 2014 Results 26Pharmacyclics Reports Second Quarter 2014 Results 27Pharmacyclics Reports Second Quarter 2014 Results 28Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 2Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 3Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 4Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 5Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 6Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 7Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 8Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014 9
Cached News: